Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (236)

71

Myeloproliferative Neoplasms in Danish Twins

enthalten in: Acta haematologica | 2018

von Andersen, M. | Bjerrum, O. | Ranjan, A. | +6

CommentIn: Acta Haematol. 2018;139(4):238-239. - PMID 29945137

72

Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response

enthalten in: Oncoimmunology | 2018

von Holmström, M. | Riley, C. | Skov, V. | +3

73

Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation

enthalten in: Oncoimmunology | 2018

von Jørgensen, M. | Holmström, M. | Martinenaite, E. | +3

74

The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms

enthalten in: Leukemia & lymphoma | 2017

von Skov, V. | Riley, C. | Thomassen, M. | +5

75

Age-Related Macular Degeneration in Patients With Chronic Myeloproliferative Neoplasms

enthalten in: JAMA ophthalmology | 2017

von Bak, M. | Sørensen, T. | Flachs, E. | +4

CommentIn: JAMA Ophthalmol. 2017 Aug 1;135(8):843-844. - PMID 28654970

76

Epigenetic changes in myelofibrosis : Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations

enthalten in: Scientific reports | 2017

von Nielsen, H. | Andersen, C. | Westman, M. | +11

ErratumIn: Sci Rep. 2018 Nov 20;8(1):17311. - PMID 30459458

77

Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs : The proof of concept in early myelofibrosis

enthalten in: Cancer | 2017

von Hasselbalch, H.

CommentOn: Cancer. 2017 Jul 15;123(14):2680-2687. - PMID 28518222

78

Anemia is present years before myelodysplastic syndrome diagnosis : Results from the pre-diagnostic period

enthalten in: American journal of hematology | 2017

von Hansen, J. | Sandholdt, H. | Siersma, V. | +7

79

Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib

enthalten in: Expert review of hematology | 2017

von Bjørn, M. | Hasselbalch, H.

80

Second malignancies in hydroxyurea and interferon-treated Philadelphia-negative myeloproliferative neoplasms

enthalten in: European journal of haematology | 2017

von Hansen, I. | Sørensen, A. | Hasselbalch, H.